Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Bio-Rad Reports First-Quarter 2017 Financial Results

Marketwired May 4, 2017

Bio-Rad to Report First-Quarter 2017 Financial Results Thursday, May 4, 2017

Marketwired April 10, 2017

Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day

PR Newswire March 13, 2017

Bio-Rad Intends to Propose Three New Independent Directors

PR Newswire March 13, 2017

Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results

Marketwired February 23, 2017

Bio-Rad to Report Fourth-Quarter and Full-Year 2016 Financial Results Thursday, February 23, 2017

Marketwired January 18, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Rad Laboratories, Inc. - BIO

PR Newswire January 18, 2017

Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property

Marketwired January 16, 2017

Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

Business Wire January 9, 2017

Microbiome MDx specialist Genetic Analysis and Bio-Rad Sign Agreement

Business Wire November 28, 2016

Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent

Marketwired November 1, 2016

Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Marketwired October 24, 2016

Globavir Announces Licensing Agreement with Bio-Rad for Globavir's Dengue Detection Technology

PR Newswire October 17, 2016

Bio-Rad to Report Third-Quarter 2016 Financial Results Tuesday, November 1, 2016

Marketwired October 10, 2016

Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

Business Wire August 10, 2016

Bio-Rad Reports Second-Quarter 2016 Financial Results

Marketwired August 3, 2016

Bio-Rad to Report Second-Quarter 2016 Financial Results Wednesday, August 3, 2016

Marketwired July 11, 2016

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Bio-Rad Laboratories, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire June 20, 2016

Attorney Appointed to Administer Affairs of Biosign and Manage CTO

Filing Services Canada May 19, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Bio-Rad Laboratories, Inc.

Accesswire May 16, 2016